[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 209 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 209

   To permanently allow an exclusion under the Supplemental Security 
 Income program and the Medicaid program for compensation provided to 
  individuals who participate in clinical trials for rare diseases or 
                              conditions.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            January 8, 2015

Mr. Doggett (for himself, Mr. McGovern, and Mr. Marino) introduced the 
following bill; which was referred to the Committee on Ways and Means, 
 and in addition to the Committee on Energy and Commerce, for a period 
    to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL


 
   To permanently allow an exclusion under the Supplemental Security 
 Income program and the Medicaid program for compensation provided to 
  individuals who participate in clinical trials for rare diseases or 
                              conditions.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ensuring Access to Clinical Trials 
Act of 2015''.

SEC. 2. ELIMINATION OF SUNSET PROVISION.

    Effective as if included in the enactment of the Improving Access 
to Clinical Trials Act of 2009 (Public Law 111-255, 124 Stat. 2640), 
section 3 of that Act is amended by striking subsection (e).
                                 <all>